NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)

Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

BOEHRINGER LABORATORIES

The following data is part of a premarket notification filed by Boehringer Laboratories with the FDA for Nicotinamide-adenine Ainucleotide (nad).

Pre-market Notification Details

Device IDK790248
510k NumberK790248
Device Name:NICOTINAMIDE-ADENINE AINUCLEOTIDE (NAD)
ClassificationNad Reduction/nadh Oxidation, Lactate Dehydrogenase
Applicant BOEHRINGER LABORATORIES 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeCFJ  
CFR Regulation Number862.1440 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1979-02-08
Decision Date1979-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.